Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2023-01-04
2024-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Yogic Breathing and Guided Meditation for Long Covid Symptoms
NCT05139979
Effect of Kinesio Tape Versus Diaphragmatic Breathing Exercise In Post COVID-19
NCT05770193
Effects of Pilates in Patients With Post- -COVID-19 Syndrome: Controlled and Randomized Clinical Trial
NCT05722730
Reconditioning Exercise for COVID-19 Patients Experiencing Residual sYmptoms
NCT04958161
Effectiveness of Technology for Metabolic Diseases Combined Sarcopenia
NCT05476536
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will be randomized to participate in either an immediate or waitlist control group that will receive the qigong sessions starting 8 weeks later. Participants will complete 3 sets of questionnaires, each about 8 weeks apart and an interview about their experiences with qigong after completing the 6 sessions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immediate
Receives 6 sessions of qigong first.
Qigong
6 sessions of combined external and internal qigong delivered in a group-based format once a week.
Waitlist Control
Receives 6 sessions of qigong after the immediate group
Qigong
6 sessions of combined external and internal qigong delivered in a group-based format once a week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Qigong
6 sessions of combined external and internal qigong delivered in a group-based format once a week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. History of a COVID-19 infection with lingering symptoms lasting longer than 12 weeks
3. Willing and able to access the internet to complete questionnaires
4. Willing and able to travel to the qigong sessions to participate in person in Sacramento, CA.
Exclusion Criteria
2. Dementia
3. Any other condition that makes it difficult for the individual to complete questionnaires or attend the qigong sessions.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michelle Dossett
Assistant Professor in Residence
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California Davis Health
Sacramento, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Joy M, Adams N, Yanuck M, Dossett ML. Experiences with Qi and changes in post-acute sequelae of COVID-19 (PASC) symptoms with qigong: a qualitative analysis of participants' experiences in a pilot clinical trial. BMC Complement Med Ther. 2025 Nov 28;25(1):434. doi: 10.1186/s12906-025-05161-w.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1846783
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.